Patents Assigned to ORASIS
  • Patent number: 11129812
    Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: September 28, 2021
    Assignee: ORASIS PHARMACEUTICALS LTD.
    Inventors: Claes Feinbaum, Franc Salamun, Sudhir Patel
  • Publication number: 20130316983
    Abstract: Methods are disclosed for treating glaucoma by treating a novel target. Methods for treating glaucoma by restoring the filtration capabilities of the endothelial lining of Schlemm's canal are provided. A method for identifying compounds capable of restoring the filtration capability of the juxtacanalicular meshwork is also provided.
    Type: Application
    Filed: May 3, 2013
    Publication date: November 28, 2013
    Applicant: ORASIS
    Inventor: ORASIS
  • Publication number: 20130295075
    Abstract: Methods are disclosed for treating glaucoma by treating a novel target. Methods for treating glaucoma by restoring the filtration capabilities of the endothelial lining of Schlemm's canal are provided. A method for identifying compounds capable of restoring the filtration capability of the juxtacanalicular meshwork is also provided.
    Type: Application
    Filed: May 3, 2013
    Publication date: November 7, 2013
    Applicant: ORASIS
    Inventor: Richard A. Hill